nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—PLA2G4A—Epirubicin—testicular cancer	0.509	0.87	CbGbCtD
Orlistat—CYP3A4—Ifosfamide—testicular cancer	0.0325	0.0556	CbGbCtD
Orlistat—CYP3A4—Vinblastine—testicular cancer	0.0173	0.0295	CbGbCtD
Orlistat—CYP3A4—Etoposide—testicular cancer	0.0155	0.0266	CbGbCtD
Orlistat—LIPF—testis—testicular cancer	0.0155	0.0944	CbGeAlD
Orlistat—PLA2G7—seminal vesicle—testicular cancer	0.012	0.0731	CbGeAlD
Orlistat—ABHD16A—seminal vesicle—testicular cancer	0.0113	0.0686	CbGeAlD
Orlistat—CYP3A4—Doxorubicin—testicular cancer	0.0106	0.0181	CbGbCtD
Orlistat—ABHD12—seminal vesicle—testicular cancer	0.0105	0.0643	CbGeAlD
Orlistat—DAGLA—testis—testicular cancer	0.00998	0.0608	CbGeAlD
Orlistat—FASN—seminal vesicle—testicular cancer	0.00885	0.054	CbGeAlD
Orlistat—DAGLB—female gonad—testicular cancer	0.00872	0.0532	CbGeAlD
Orlistat—DAGLB—testis—testicular cancer	0.00774	0.0471	CbGeAlD
Orlistat—PLA2G7—female gonad—testicular cancer	0.00705	0.0429	CbGeAlD
Orlistat—ABHD16A—female gonad—testicular cancer	0.00661	0.0403	CbGeAlD
Orlistat—PNLIP—female gonad—testicular cancer	0.0062	0.0378	CbGeAlD
Orlistat—ABHD12—female gonad—testicular cancer	0.0062	0.0378	CbGeAlD
Orlistat—ABHD16A—testis—testicular cancer	0.00586	0.0357	CbGeAlD
Orlistat—PLA2G4A—Raltitrexed—Methotrexate—testicular cancer	0.00565	1	CbGdCrCtD
Orlistat—DAGLB—lymph node—testicular cancer	0.00561	0.0342	CbGeAlD
Orlistat—ABHD12—testis—testicular cancer	0.00549	0.0335	CbGeAlD
Orlistat—FASN—female gonad—testicular cancer	0.0052	0.0317	CbGeAlD
Orlistat—FASN—testis—testicular cancer	0.00461	0.0281	CbGeAlD
Orlistat—PLA2G7—lymph node—testicular cancer	0.00453	0.0276	CbGeAlD
Orlistat—PLA2G4A—seminal vesicle—testicular cancer	0.00426	0.0259	CbGeAlD
Orlistat—ABHD16A—lymph node—testicular cancer	0.00425	0.0259	CbGeAlD
Orlistat—ABHD12—lymph node—testicular cancer	0.00398	0.0243	CbGeAlD
Orlistat—FASN—lymph node—testicular cancer	0.00334	0.0204	CbGeAlD
Orlistat—PLA2G4A—female gonad—testicular cancer	0.0025	0.0152	CbGeAlD
Orlistat—PLA2G4A—testis—testicular cancer	0.00222	0.0135	CbGeAlD
Orlistat—PLA2G4A—lymph node—testicular cancer	0.00161	0.00979	CbGeAlD
Orlistat—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000301	0.00123	CcSEcCtD
Orlistat—Skin disorder—Etoposide—testicular cancer	0.000299	0.00122	CcSEcCtD
Orlistat—Dry skin—Doxorubicin—testicular cancer	0.000297	0.00121	CcSEcCtD
Orlistat—Hyperhidrosis—Etoposide—testicular cancer	0.000297	0.00121	CcSEcCtD
Orlistat—Pancreatitis—Epirubicin—testicular cancer	0.000297	0.00121	CcSEcCtD
Orlistat—Abdominal pain upper—Doxorubicin—testicular cancer	0.000296	0.00121	CcSEcCtD
Orlistat—Hypokalaemia—Doxorubicin—testicular cancer	0.000295	0.0012	CcSEcCtD
Orlistat—Breast disorder—Doxorubicin—testicular cancer	0.000293	0.0012	CcSEcCtD
Orlistat—Decreased appetite—Cisplatin—testicular cancer	0.000292	0.00119	CcSEcCtD
Orlistat—Diarrhoea—Dactinomycin—testicular cancer	0.000291	0.00118	CcSEcCtD
Orlistat—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00029	0.00118	CcSEcCtD
Orlistat—Vomiting—Bleomycin—testicular cancer	0.00029	0.00118	CcSEcCtD
Orlistat—Infestation—Methotrexate—testicular cancer	0.000289	0.00118	CcSEcCtD
Orlistat—Infestation NOS—Methotrexate—testicular cancer	0.000289	0.00118	CcSEcCtD
Orlistat—Depression—Methotrexate—testicular cancer	0.000288	0.00117	CcSEcCtD
Orlistat—Rash—Bleomycin—testicular cancer	0.000287	0.00117	CcSEcCtD
Orlistat—Gastritis—Doxorubicin—testicular cancer	0.000287	0.00117	CcSEcCtD
Orlistat—Pain—Cisplatin—testicular cancer	0.000287	0.00117	CcSEcCtD
Orlistat—Dermatitis—Bleomycin—testicular cancer	0.000287	0.00117	CcSEcCtD
Orlistat—Hypersensitivity—Ifosfamide—testicular cancer	0.000287	0.00117	CcSEcCtD
Orlistat—Renal failure—Methotrexate—testicular cancer	0.000284	0.00116	CcSEcCtD
Orlistat—Abdominal distension—Doxorubicin—testicular cancer	0.000282	0.00115	CcSEcCtD
Orlistat—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000282	0.00115	CcSEcCtD
Orlistat—Influenza—Doxorubicin—testicular cancer	0.00028	0.00114	CcSEcCtD
Orlistat—Asthma—Doxorubicin—testicular cancer	0.00028	0.00114	CcSEcCtD
Orlistat—Asthenia—Ifosfamide—testicular cancer	0.000279	0.00114	CcSEcCtD
Orlistat—Feeling abnormal—Cisplatin—testicular cancer	0.000276	0.00113	CcSEcCtD
Orlistat—Paraesthesia—Etoposide—testicular cancer	0.000276	0.00113	CcSEcCtD
Orlistat—Pruritus—Ifosfamide—testicular cancer	0.000275	0.00112	CcSEcCtD
Orlistat—Pancreatitis—Doxorubicin—testicular cancer	0.000275	0.00112	CcSEcCtD
Orlistat—Hepatobiliary disease—Methotrexate—testicular cancer	0.000273	0.00111	CcSEcCtD
Orlistat—Nausea—Bleomycin—testicular cancer	0.00027	0.0011	CcSEcCtD
Orlistat—Infestation NOS—Epirubicin—testicular cancer	0.00027	0.0011	CcSEcCtD
Orlistat—Infestation—Epirubicin—testicular cancer	0.00027	0.0011	CcSEcCtD
Orlistat—Vomiting—Dactinomycin—testicular cancer	0.00027	0.0011	CcSEcCtD
Orlistat—Rash—Dactinomycin—testicular cancer	0.000268	0.00109	CcSEcCtD
Orlistat—Decreased appetite—Etoposide—testicular cancer	0.000267	0.00109	CcSEcCtD
Orlistat—Diarrhoea—Ifosfamide—testicular cancer	0.000266	0.00109	CcSEcCtD
Orlistat—Renal failure—Epirubicin—testicular cancer	0.000266	0.00108	CcSEcCtD
Orlistat—Gastrointestinal disorder—Etoposide—testicular cancer	0.000265	0.00108	CcSEcCtD
Orlistat—Body temperature increased—Cisplatin—testicular cancer	0.000265	0.00108	CcSEcCtD
Orlistat—Fatigue—Etoposide—testicular cancer	0.000265	0.00108	CcSEcCtD
Orlistat—Neuropathy peripheral—Epirubicin—testicular cancer	0.000265	0.00108	CcSEcCtD
Orlistat—Pain—Etoposide—testicular cancer	0.000263	0.00107	CcSEcCtD
Orlistat—Urinary tract infection—Epirubicin—testicular cancer	0.000263	0.00107	CcSEcCtD
Orlistat—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000261	0.00106	CcSEcCtD
Orlistat—Haemoglobin—Methotrexate—testicular cancer	0.00026	0.00106	CcSEcCtD
Orlistat—Haemorrhage—Methotrexate—testicular cancer	0.000259	0.00106	CcSEcCtD
Orlistat—Hepatitis—Methotrexate—testicular cancer	0.000259	0.00106	CcSEcCtD
Orlistat—Dizziness—Ifosfamide—testicular cancer	0.000257	0.00105	CcSEcCtD
Orlistat—Pharyngitis—Methotrexate—testicular cancer	0.000257	0.00105	CcSEcCtD
Orlistat—Urinary tract disorder—Methotrexate—testicular cancer	0.000256	0.00104	CcSEcCtD
Orlistat—Hepatobiliary disease—Epirubicin—testicular cancer	0.000255	0.00104	CcSEcCtD
Orlistat—Urethral disorder—Methotrexate—testicular cancer	0.000254	0.00104	CcSEcCtD
Orlistat—Sinusitis—Epirubicin—testicular cancer	0.000253	0.00103	CcSEcCtD
Orlistat—Feeling abnormal—Etoposide—testicular cancer	0.000253	0.00103	CcSEcCtD
Orlistat—Nausea—Dactinomycin—testicular cancer	0.000252	0.00103	CcSEcCtD
Orlistat—Gastrointestinal pain—Etoposide—testicular cancer	0.000251	0.00102	CcSEcCtD
Orlistat—Infestation NOS—Doxorubicin—testicular cancer	0.00025	0.00102	CcSEcCtD
Orlistat—Infestation—Doxorubicin—testicular cancer	0.00025	0.00102	CcSEcCtD
Orlistat—Vomiting—Ifosfamide—testicular cancer	0.000247	0.00101	CcSEcCtD
Orlistat—Hypersensitivity—Cisplatin—testicular cancer	0.000247	0.00101	CcSEcCtD
Orlistat—Renal failure—Doxorubicin—testicular cancer	0.000246	0.001	CcSEcCtD
Orlistat—Rash—Ifosfamide—testicular cancer	0.000245	0.001	CcSEcCtD
Orlistat—Dermatitis—Ifosfamide—testicular cancer	0.000245	0.001	CcSEcCtD
Orlistat—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000245	0.000999	CcSEcCtD
Orlistat—Urticaria—Etoposide—testicular cancer	0.000244	0.000996	CcSEcCtD
Orlistat—Haemoglobin—Epirubicin—testicular cancer	0.000244	0.000994	CcSEcCtD
Orlistat—Abdominal pain—Etoposide—testicular cancer	0.000243	0.000991	CcSEcCtD
Orlistat—Body temperature increased—Etoposide—testicular cancer	0.000243	0.000991	CcSEcCtD
Orlistat—Urinary tract infection—Doxorubicin—testicular cancer	0.000243	0.000991	CcSEcCtD
Orlistat—Haemorrhage—Epirubicin—testicular cancer	0.000242	0.000989	CcSEcCtD
Orlistat—Hepatitis—Epirubicin—testicular cancer	0.000242	0.000989	CcSEcCtD
Orlistat—Asthenia—Cisplatin—testicular cancer	0.000241	0.000981	CcSEcCtD
Orlistat—Pharyngitis—Epirubicin—testicular cancer	0.000241	0.000981	CcSEcCtD
Orlistat—Urinary tract disorder—Epirubicin—testicular cancer	0.000239	0.000976	CcSEcCtD
Orlistat—Oedema peripheral—Epirubicin—testicular cancer	0.000239	0.000974	CcSEcCtD
Orlistat—Urethral disorder—Epirubicin—testicular cancer	0.000238	0.000969	CcSEcCtD
Orlistat—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000236	0.000964	CcSEcCtD
Orlistat—Sinusitis—Doxorubicin—testicular cancer	0.000234	0.000956	CcSEcCtD
Orlistat—Immune system disorder—Methotrexate—testicular cancer	0.000234	0.000954	CcSEcCtD
Orlistat—Mediastinal disorder—Methotrexate—testicular cancer	0.000234	0.000952	CcSEcCtD
Orlistat—Nausea—Ifosfamide—testicular cancer	0.000231	0.000942	CcSEcCtD
Orlistat—Diarrhoea—Cisplatin—testicular cancer	0.00023	0.000936	CcSEcCtD
Orlistat—Alopecia—Methotrexate—testicular cancer	0.000229	0.000934	CcSEcCtD
Orlistat—Mental disorder—Methotrexate—testicular cancer	0.000227	0.000926	CcSEcCtD
Orlistat—Hypersensitivity—Etoposide—testicular cancer	0.000226	0.000923	CcSEcCtD
Orlistat—Malnutrition—Methotrexate—testicular cancer	0.000226	0.00092	CcSEcCtD
Orlistat—Haemoglobin—Doxorubicin—testicular cancer	0.000226	0.00092	CcSEcCtD
Orlistat—Haemorrhage—Doxorubicin—testicular cancer	0.000224	0.000915	CcSEcCtD
Orlistat—Hepatitis—Doxorubicin—testicular cancer	0.000224	0.000915	CcSEcCtD
Orlistat—Pharyngitis—Doxorubicin—testicular cancer	0.000223	0.000908	CcSEcCtD
Orlistat—Urinary tract disorder—Doxorubicin—testicular cancer	0.000222	0.000903	CcSEcCtD
Orlistat—Oedema peripheral—Doxorubicin—testicular cancer	0.000221	0.000901	CcSEcCtD
Orlistat—Dysgeusia—Methotrexate—testicular cancer	0.000221	0.000901	CcSEcCtD
Orlistat—Asthenia—Etoposide—testicular cancer	0.000221	0.000899	CcSEcCtD
Orlistat—Urethral disorder—Doxorubicin—testicular cancer	0.00022	0.000897	CcSEcCtD
Orlistat—Immune system disorder—Epirubicin—testicular cancer	0.000219	0.000893	CcSEcCtD
Orlistat—Mediastinal disorder—Epirubicin—testicular cancer	0.000219	0.000891	CcSEcCtD
Orlistat—Back pain—Methotrexate—testicular cancer	0.000218	0.00089	CcSEcCtD
Orlistat—Pruritus—Etoposide—testicular cancer	0.000217	0.000887	CcSEcCtD
Orlistat—Alopecia—Epirubicin—testicular cancer	0.000214	0.000874	CcSEcCtD
Orlistat—Vomiting—Cisplatin—testicular cancer	0.000213	0.00087	CcSEcCtD
Orlistat—Vision blurred—Methotrexate—testicular cancer	0.000213	0.000867	CcSEcCtD
Orlistat—Mental disorder—Epirubicin—testicular cancer	0.000212	0.000866	CcSEcCtD
Orlistat—Rash—Cisplatin—testicular cancer	0.000212	0.000862	CcSEcCtD
Orlistat—Dermatitis—Cisplatin—testicular cancer	0.000211	0.000862	CcSEcCtD
Orlistat—Malnutrition—Epirubicin—testicular cancer	0.000211	0.000861	CcSEcCtD
Orlistat—Diarrhoea—Etoposide—testicular cancer	0.00021	0.000857	CcSEcCtD
Orlistat—Ill-defined disorder—Methotrexate—testicular cancer	0.000209	0.000853	CcSEcCtD
Orlistat—Flatulence—Epirubicin—testicular cancer	0.000208	0.000848	CcSEcCtD
Orlistat—Dysgeusia—Epirubicin—testicular cancer	0.000207	0.000843	CcSEcCtD
Orlistat—Back pain—Epirubicin—testicular cancer	0.000204	0.000833	CcSEcCtD
Orlistat—Malaise—Methotrexate—testicular cancer	0.000203	0.000829	CcSEcCtD
Orlistat—Dizziness—Etoposide—testicular cancer	0.000203	0.000829	CcSEcCtD
Orlistat—Muscle spasms—Epirubicin—testicular cancer	0.000203	0.000828	CcSEcCtD
Orlistat—Immune system disorder—Doxorubicin—testicular cancer	0.000203	0.000826	CcSEcCtD
Orlistat—Vertigo—Methotrexate—testicular cancer	0.000203	0.000826	CcSEcCtD
Orlistat—Mediastinal disorder—Doxorubicin—testicular cancer	0.000202	0.000825	CcSEcCtD
Orlistat—Nausea—Cisplatin—testicular cancer	0.000199	0.000813	CcSEcCtD
Orlistat—Vision blurred—Epirubicin—testicular cancer	0.000199	0.000811	CcSEcCtD
Orlistat—Alopecia—Doxorubicin—testicular cancer	0.000198	0.000808	CcSEcCtD
Orlistat—Cough—Methotrexate—testicular cancer	0.000197	0.000803	CcSEcCtD
Orlistat—Mental disorder—Doxorubicin—testicular cancer	0.000197	0.000802	CcSEcCtD
Orlistat—Ill-defined disorder—Epirubicin—testicular cancer	0.000196	0.000799	CcSEcCtD
Orlistat—Convulsion—Methotrexate—testicular cancer	0.000195	0.000797	CcSEcCtD
Orlistat—Vomiting—Etoposide—testicular cancer	0.000195	0.000797	CcSEcCtD
Orlistat—Malnutrition—Doxorubicin—testicular cancer	0.000195	0.000796	CcSEcCtD
Orlistat—Rash—Etoposide—testicular cancer	0.000194	0.00079	CcSEcCtD
Orlistat—Dermatitis—Etoposide—testicular cancer	0.000194	0.000789	CcSEcCtD
Orlistat—Headache—Etoposide—testicular cancer	0.000193	0.000785	CcSEcCtD
Orlistat—Flatulence—Doxorubicin—testicular cancer	0.000192	0.000785	CcSEcCtD
Orlistat—Chest pain—Methotrexate—testicular cancer	0.000192	0.000783	CcSEcCtD
Orlistat—Myalgia—Methotrexate—testicular cancer	0.000192	0.000783	CcSEcCtD
Orlistat—Dysgeusia—Doxorubicin—testicular cancer	0.000191	0.00078	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000191	0.000778	CcSEcCtD
Orlistat—Malaise—Epirubicin—testicular cancer	0.00019	0.000776	CcSEcCtD
Orlistat—Discomfort—Methotrexate—testicular cancer	0.00019	0.000774	CcSEcCtD
Orlistat—Vertigo—Epirubicin—testicular cancer	0.00019	0.000773	CcSEcCtD
Orlistat—Back pain—Doxorubicin—testicular cancer	0.000189	0.00077	CcSEcCtD
Orlistat—Muscle spasms—Doxorubicin—testicular cancer	0.000188	0.000766	CcSEcCtD
Orlistat—Palpitations—Epirubicin—testicular cancer	0.000187	0.000761	CcSEcCtD
Orlistat—Cough—Epirubicin—testicular cancer	0.000184	0.000751	CcSEcCtD
Orlistat—Anaphylactic shock—Methotrexate—testicular cancer	0.000184	0.000751	CcSEcCtD
Orlistat—Vision blurred—Doxorubicin—testicular cancer	0.000184	0.000751	CcSEcCtD
Orlistat—Convulsion—Epirubicin—testicular cancer	0.000183	0.000746	CcSEcCtD
Orlistat—Infection—Methotrexate—testicular cancer	0.000183	0.000746	CcSEcCtD
Orlistat—Nausea—Etoposide—testicular cancer	0.000183	0.000744	CcSEcCtD
Orlistat—Ill-defined disorder—Doxorubicin—testicular cancer	0.000181	0.000739	CcSEcCtD
Orlistat—Nervous system disorder—Methotrexate—testicular cancer	0.000181	0.000736	CcSEcCtD
Orlistat—Chest pain—Epirubicin—testicular cancer	0.00018	0.000733	CcSEcCtD
Orlistat—Myalgia—Epirubicin—testicular cancer	0.00018	0.000733	CcSEcCtD
Orlistat—Anxiety—Epirubicin—testicular cancer	0.000179	0.00073	CcSEcCtD
Orlistat—Skin disorder—Methotrexate—testicular cancer	0.000179	0.000729	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000178	0.000728	CcSEcCtD
Orlistat—Hyperhidrosis—Methotrexate—testicular cancer	0.000178	0.000726	CcSEcCtD
Orlistat—Discomfort—Epirubicin—testicular cancer	0.000178	0.000724	CcSEcCtD
Orlistat—Malaise—Doxorubicin—testicular cancer	0.000176	0.000718	CcSEcCtD
Orlistat—Dry mouth—Epirubicin—testicular cancer	0.000176	0.000717	CcSEcCtD
Orlistat—Vertigo—Doxorubicin—testicular cancer	0.000175	0.000716	CcSEcCtD
Orlistat—Palpitations—Doxorubicin—testicular cancer	0.000173	0.000704	CcSEcCtD
Orlistat—Oedema—Epirubicin—testicular cancer	0.000172	0.000702	CcSEcCtD
Orlistat—Anaphylactic shock—Epirubicin—testicular cancer	0.000172	0.000702	CcSEcCtD
Orlistat—Infection—Epirubicin—testicular cancer	0.000171	0.000698	CcSEcCtD
Orlistat—Cough—Doxorubicin—testicular cancer	0.00017	0.000695	CcSEcCtD
Orlistat—Convulsion—Doxorubicin—testicular cancer	0.000169	0.00069	CcSEcCtD
Orlistat—Nervous system disorder—Epirubicin—testicular cancer	0.000169	0.000689	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000168	0.000684	CcSEcCtD
Orlistat—Skin disorder—Epirubicin—testicular cancer	0.000167	0.000682	CcSEcCtD
Orlistat—Hyperhidrosis—Epirubicin—testicular cancer	0.000167	0.000679	CcSEcCtD
Orlistat—Insomnia—Methotrexate—testicular cancer	0.000167	0.000679	CcSEcCtD
Orlistat—Chest pain—Doxorubicin—testicular cancer	0.000166	0.000678	CcSEcCtD
Orlistat—Myalgia—Doxorubicin—testicular cancer	0.000166	0.000678	CcSEcCtD
Orlistat—Anxiety—Doxorubicin—testicular cancer	0.000166	0.000676	CcSEcCtD
Orlistat—Paraesthesia—Methotrexate—testicular cancer	0.000165	0.000674	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000165	0.000673	CcSEcCtD
Orlistat—Discomfort—Doxorubicin—testicular cancer	0.000164	0.00067	CcSEcCtD
Orlistat—Dry mouth—Doxorubicin—testicular cancer	0.000163	0.000663	CcSEcCtD
Orlistat—Dyspepsia—Methotrexate—testicular cancer	0.000162	0.000661	CcSEcCtD
Orlistat—Decreased appetite—Methotrexate—testicular cancer	0.00016	0.000653	CcSEcCtD
Orlistat—Oedema—Doxorubicin—testicular cancer	0.000159	0.00065	CcSEcCtD
Orlistat—Anaphylactic shock—Doxorubicin—testicular cancer	0.000159	0.00065	CcSEcCtD
Orlistat—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000159	0.000648	CcSEcCtD
Orlistat—Fatigue—Methotrexate—testicular cancer	0.000159	0.000647	CcSEcCtD
Orlistat—Infection—Doxorubicin—testicular cancer	0.000158	0.000646	CcSEcCtD
Orlistat—Pain—Methotrexate—testicular cancer	0.000157	0.000642	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000157	0.00064	CcSEcCtD
Orlistat—Nervous system disorder—Doxorubicin—testicular cancer	0.000156	0.000637	CcSEcCtD
Orlistat—Insomnia—Epirubicin—testicular cancer	0.000156	0.000635	CcSEcCtD
Orlistat—Skin disorder—Doxorubicin—testicular cancer	0.000155	0.000631	CcSEcCtD
Orlistat—Paraesthesia—Epirubicin—testicular cancer	0.000155	0.000631	CcSEcCtD
Orlistat—Hyperhidrosis—Doxorubicin—testicular cancer	0.000154	0.000628	CcSEcCtD
Orlistat—Feeling abnormal—Methotrexate—testicular cancer	0.000152	0.000619	CcSEcCtD
Orlistat—Dyspepsia—Epirubicin—testicular cancer	0.000152	0.000618	CcSEcCtD
Orlistat—Gastrointestinal pain—Methotrexate—testicular cancer	0.000151	0.000614	CcSEcCtD
Orlistat—Decreased appetite—Epirubicin—testicular cancer	0.00015	0.000611	CcSEcCtD
Orlistat—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000149	0.000606	CcSEcCtD
Orlistat—Fatigue—Epirubicin—testicular cancer	0.000149	0.000606	CcSEcCtD
Orlistat—Pain—Epirubicin—testicular cancer	0.000147	0.000601	CcSEcCtD
Orlistat—Urticaria—Methotrexate—testicular cancer	0.000146	0.000596	CcSEcCtD
Orlistat—Abdominal pain—Methotrexate—testicular cancer	0.000146	0.000593	CcSEcCtD
Orlistat—Body temperature increased—Methotrexate—testicular cancer	0.000146	0.000593	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000145	0.000592	CcSEcCtD
Orlistat—Insomnia—Doxorubicin—testicular cancer	0.000144	0.000588	CcSEcCtD
Orlistat—Paraesthesia—Doxorubicin—testicular cancer	0.000143	0.000584	CcSEcCtD
Orlistat—Feeling abnormal—Epirubicin—testicular cancer	0.000142	0.000579	CcSEcCtD
Orlistat—Gastrointestinal pain—Epirubicin—testicular cancer	0.000141	0.000574	CcSEcCtD
Orlistat—Dyspepsia—Doxorubicin—testicular cancer	0.00014	0.000572	CcSEcCtD
Orlistat—Decreased appetite—Doxorubicin—testicular cancer	0.000139	0.000565	CcSEcCtD
Orlistat—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000138	0.000561	CcSEcCtD
Orlistat—Fatigue—Doxorubicin—testicular cancer	0.000137	0.00056	CcSEcCtD
Orlistat—Urticaria—Epirubicin—testicular cancer	0.000137	0.000558	CcSEcCtD
Orlistat—Pain—Doxorubicin—testicular cancer	0.000136	0.000556	CcSEcCtD
Orlistat—Abdominal pain—Epirubicin—testicular cancer	0.000136	0.000555	CcSEcCtD
Orlistat—Body temperature increased—Epirubicin—testicular cancer	0.000136	0.000555	CcSEcCtD
Orlistat—Hypersensitivity—Methotrexate—testicular cancer	0.000136	0.000553	CcSEcCtD
Orlistat—Asthenia—Methotrexate—testicular cancer	0.000132	0.000539	CcSEcCtD
Orlistat—Feeling abnormal—Doxorubicin—testicular cancer	0.000131	0.000536	CcSEcCtD
Orlistat—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00013	0.000531	CcSEcCtD
Orlistat—Pruritus—Methotrexate—testicular cancer	0.00013	0.000531	CcSEcCtD
Orlistat—Hypersensitivity—Epirubicin—testicular cancer	0.000127	0.000518	CcSEcCtD
Orlistat—Urticaria—Doxorubicin—testicular cancer	0.000127	0.000516	CcSEcCtD
Orlistat—Abdominal pain—Doxorubicin—testicular cancer	0.000126	0.000514	CcSEcCtD
Orlistat—Body temperature increased—Doxorubicin—testicular cancer	0.000126	0.000514	CcSEcCtD
Orlistat—Diarrhoea—Methotrexate—testicular cancer	0.000126	0.000514	CcSEcCtD
Orlistat—Asthenia—Epirubicin—testicular cancer	0.000124	0.000504	CcSEcCtD
Orlistat—Pruritus—Epirubicin—testicular cancer	0.000122	0.000497	CcSEcCtD
Orlistat—Dizziness—Methotrexate—testicular cancer	0.000122	0.000496	CcSEcCtD
Orlistat—Diarrhoea—Epirubicin—testicular cancer	0.000118	0.000481	CcSEcCtD
Orlistat—Hypersensitivity—Doxorubicin—testicular cancer	0.000117	0.000479	CcSEcCtD
Orlistat—Vomiting—Methotrexate—testicular cancer	0.000117	0.000477	CcSEcCtD
Orlistat—Rash—Methotrexate—testicular cancer	0.000116	0.000473	CcSEcCtD
Orlistat—Dermatitis—Methotrexate—testicular cancer	0.000116	0.000473	CcSEcCtD
Orlistat—Headache—Methotrexate—testicular cancer	0.000115	0.00047	CcSEcCtD
Orlistat—Asthenia—Doxorubicin—testicular cancer	0.000114	0.000466	CcSEcCtD
Orlistat—Dizziness—Epirubicin—testicular cancer	0.000114	0.000465	CcSEcCtD
Orlistat—Pruritus—Doxorubicin—testicular cancer	0.000113	0.00046	CcSEcCtD
Orlistat—Vomiting—Epirubicin—testicular cancer	0.00011	0.000447	CcSEcCtD
Orlistat—Nausea—Methotrexate—testicular cancer	0.000109	0.000446	CcSEcCtD
Orlistat—Diarrhoea—Doxorubicin—testicular cancer	0.000109	0.000445	CcSEcCtD
Orlistat—Rash—Epirubicin—testicular cancer	0.000109	0.000443	CcSEcCtD
Orlistat—Dermatitis—Epirubicin—testicular cancer	0.000109	0.000443	CcSEcCtD
Orlistat—Headache—Epirubicin—testicular cancer	0.000108	0.00044	CcSEcCtD
Orlistat—Dizziness—Doxorubicin—testicular cancer	0.000105	0.00043	CcSEcCtD
Orlistat—Nausea—Epirubicin—testicular cancer	0.000102	0.000417	CcSEcCtD
Orlistat—Vomiting—Doxorubicin—testicular cancer	0.000101	0.000413	CcSEcCtD
Orlistat—Rash—Doxorubicin—testicular cancer	0.000101	0.00041	CcSEcCtD
Orlistat—Dermatitis—Doxorubicin—testicular cancer	0.0001	0.000409	CcSEcCtD
Orlistat—Headache—Doxorubicin—testicular cancer	9.99e-05	0.000407	CcSEcCtD
Orlistat—Nausea—Doxorubicin—testicular cancer	9.47e-05	0.000386	CcSEcCtD
